HHS Rebate Plan A Leap Of Faith? Lower Costs Hinge On Drug Firm, Plan Response

 
• By Cathy Kelly

HHS seeks input on how stakeholders might adjust to a system without rebates and requests comments on three actuarial reports that attempt to project the financial impact of the change.

Silhouette of man jumping over cliff on sunset background , business concept

More from Pricing Debate

More from Market Access